2m 2m 2m 2m 2m 2m 2m
BIOAGE LABS (BIOA)
NASDAQ
$22.23+$0.44 (+2.04%)
Price as of Jul 14, 2026 9:23 AM EDT- $968.4MMarket Cap
- 370.52%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
BIOAGE LABS (BIOA)
$22.23+$0.44 (+2.04%)
BIOA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $21.79 | ||
Change | -$2.55 (-10.50%) | ||
Open | $23.82 | ||
High | $23.87 | ||
Low | $21.45 | ||
Previous Close | $24.34 | ||
Volume | 548,913 | ||
30-Day Average Volume | 769,471 | ||
1-Week Change | -12.30% | ||
1-Month Change | 20.76% | ||
1-Year Change | 370.52% | ||
3-Year Change | 13,524.14% | ||
5-Year Change | 13,524.14% | ||
Fundamentals | |||
Shares Outstanding | 44.5M | ||
Total Assets | $397.7M | ||
Market Cap | $968.4M | ||
Enterprise Value | $727.8M | ||
Period: QTR TTM FY | |||
Revenue | $2.8M | ||
Net Income | -$22.3M | ||
Free Cash Flow | -$24.1M | ||
EBIT | -$22.2M | ||
EBITDA | -$22.1M | ||
Net Working Capital | $376.0M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -33 | ||
Enterprise Value/Revenue | 263 | ||
P/B | 3 | ||
P/E | -42 | ||
PEG | -2 | ||
Price/Free Cash Flow | -40 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue